- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Guangxi Cancer Hospital
Total 10040 results
-
Zhejiang Cancer HospitalCompletedSafety Issues | Effect of DrugsChina
-
Fujian Cancer HospitalUnknown
-
Barretos Cancer HospitalUnknownColorectal Cancer | AdenomaBrazil
-
Barretos Cancer HospitalUnknownRadiotherapy; Complications
-
Hangzhou Cancer HospitalUnknownEsophageal Cancer | Stereotactic Body Radiation Therapy | Metastatic Esophageal Cancer | ThymalfasinChina
-
Barretos Cancer HospitalCompletedCervical Intraepithelial Neoplasia | Cervix NeoplasmBrazil
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Barretos Cancer HospitalCompleted
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Fujian Cancer HospitalUnknownAdvanced Gastric Cancer Adenocarcinoma of Esophagogastric JunctionChina
-
Ningbo Cancer HospitalUnknownChemotherapy | Advanced Lung Cancer | Precision Cell ImmunotherapyChina
-
Ningbo Cancer HospitalUnknownAdvanced Liver Cancer | Precision Cell Immunotherapy | Transcatheter Arterial ChemoembolizationChina
-
Zhejiang Cancer HospitalUnknown
-
Barretos Cancer HospitalCompletedWound Infection | CicatrizationBrazil
-
Barretos Cancer HospitalCompletedPain | Cancer | Terminal Disease
-
Theagenio Cancer HospitalCompletedMultiple Pulmonary NodulesGreece
-
Barretos Cancer HospitalCompleted
-
Barretos Cancer HospitalWithdrawn
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownDrug Safety | Surgically-Created Resection CavityChina
-
Zhejiang Cancer HospitalCompleted
-
Zhejiang Cancer HospitalCompletedEsophageal CancerChina
-
Zhejiang Cancer HospitalCompletedUltrasonography | Lipemia | Endometrium | Mammography | EstrogenChina
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung CancerChina
-
Wei JiangWuzhou Red Cross Hospital; Guangxi Naxishan Hospital; LiuZhou People's Hospital; Guigang People's Hospital and other collaboratorsUnknown
-
Taizhou HospitalTaizhou Enze Medical Center (Group) Enze Hospital; Taizhou Cancer HospitalRecruitingNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalNot yet recruiting
-
Henan Cancer HospitalRecruitingNon-Small Cell Lung CancerChina
-
Zhejiang Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruitingExtensive Stage Lung Small Cell CancerChina
-
Henan Cancer HospitalRecruitingNon-Squamous Non-Small Cell Lung CancerChina
-
Fujian Cancer HospitalNot yet recruiting
-
Fujian Cancer HospitalRecruitingRectal Diseases | Radiation InjuriesChina
-
Zhejiang Cancer HospitalNot yet recruiting
-
Henan Cancer HospitalRecruitingAcute Myeloid Leukemia | Thalidomide | Maintenance Treatment | Minor Residue Disease | Interferon-α-1b | Interleukin-2 | Venentoclax | AzacitidineChina
-
Fujian Cancer HospitalNot yet recruiting
-
Zhejiang Cancer HospitalRecruitingBiliary Tract CarcinomaChina
-
Fujian Cancer HospitalNot yet recruitingMRI | Cervical Cancer | Radiotherapy | Prognostic ModelChina
-
Fujian Cancer HospitalNot yet recruiting
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Zhejiang Cancer HospitalNot yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
Fujian Cancer HospitalNot yet recruitingCervical Cancer | Radiotherapy | Risk Factor | Prognostic Model | Distant MetastasisChina
-
Fujian Cancer HospitalNot yet recruitingNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalRecruitingCholangiocarcinoma | Biliary Tract TumorChina
-
Zhejiang Cancer HospitalRecruitingGastric Cancer | Peritoneal Metastases | Ascites, MalignantChina
-
Fujian Cancer HospitalNot yet recruiting
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Zhejiang Cancer HospitalRecruitingRituximab, Lenalidomide, Zebutinib ,Mantle Cell LymphomaChina